down arrow

23andMe Holding Co.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90138Q1085
USD
3.50
-0.1 (-2.78%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
bluebird bio, Inc.
MaxCyte, Inc.
uniQure NV
Humacyte, Inc.
Precigen, Inc.
23andMe Holding Co.
Voyager Therapeutics, Inc.
Terns Pharmaceuticals, Inc.
Aura Biosciences, Inc.
Aldeyra Therapeutics, Inc.
Renovaro, Inc.
Why is 23andMe Holding Co. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate -190.83% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -257.20
2
Flat results in Jun 25
  • ROCE(HY) Lowest at -430.33%
  • DEBT-EQUITY RATIO (HY) Highest at 30.68 %
  • DEBTORS TURNOVER RATIO(HY) Lowest at 7.29 times
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -3.05%, its profits have risen by 34.6%
4
Below par performance in long term as well as near term
  • Along with generating -3.05% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is 23andMe Holding Co. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
23andMe Holding Co.
-3.05%
-0.22
255.16%
S&P 500
15.37%
0.56
19.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.16%
EBIT Growth (5y)
-190.83%
EBIT to Interest (avg)
-257.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.45
Sales to Capital Employed (avg)
-1.17
Tax Ratio
0.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
37.42%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.42
EV to EBIT
-0.36
EV to EBITDA
-0.40
EV to Capital Employed
-6.16
EV to Sales
0.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-328.10%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -3.13% (YoY

PRE-TAX PROFIT(Q)

At USD -30.64 MM has Grown at 55.86%

NET PROFIT(Q)

At USD -23.83 MM has Grown at 65.67%

EPS(Q)

Highest at USD -0.87

-12What is not working for the Company
ROCE(HY)

Lowest at -430.33%

DEBT-EQUITY RATIO (HY)

Highest at 30.68 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 7.29 times

NET SALES(Q)

Lowest at USD 25.42 MM

Here's what is working for 23andMe Holding Co.
Pre-Tax Profit
At USD -30.64 MM has Grown at 55.86%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
At USD -23.83 MM has Grown at 65.67%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.87
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -3.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for 23andMe Holding Co.
Net Sales
At USD 25.42 MM has Fallen at -37.1%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Net Sales
Lowest at USD 25.42 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Debt-Equity Ratio
Highest at 30.68 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 7.29 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."